Effect of axial ligation and delivery system on the tumour-localising and -photosensitising properties of Ge(IV)-octabutoxy-phthalocyanines

Four Ge(IV)-octabutoxy-phthalocyanines (GePcs) bearing two alkyl-type axial ligands were assayed for their pharmacokinetic properties and phototherapeutic efficiency in Balb/c mice bearing an intramuscularly transplanted MS-2 fibrosarcoma. The GePcs were i.v. injected at a dose of 0.35 mumol kg-1 bo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of cancer 1995-04, Vol.71 (4), p.727-732
Hauptverfasser: Soncin, M, Polo, L, Reddi, E, Jori, G, Kenney, ME, Cheng, G, Rodgers, MAJ
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 732
container_issue 4
container_start_page 727
container_title British journal of cancer
container_volume 71
creator Soncin, M
Polo, L
Reddi, E
Jori, G
Kenney, ME
Cheng, G
Rodgers, MAJ
description Four Ge(IV)-octabutoxy-phthalocyanines (GePcs) bearing two alkyl-type axial ligands were assayed for their pharmacokinetic properties and phototherapeutic efficiency in Balb/c mice bearing an intramuscularly transplanted MS-2 fibrosarcoma. The GePcs were i.v. injected at a dose of 0.35 mumol kg-1 body weight after incorporation into either Cremophor emulsions or small unilamellar liposomes of dipalmitoyl-phosphatidylcholine (DPPC). Both the nature of the delivery system and the chemical structure of the phthalocyanine were found to affect the behaviour of the GePcs in vivo. Thus, Cremophor-administered GePcs invariably yielded a more prolonged serum retention and a larger association with low-density lipoproteins (LDLs) as compared with the corresponding liposome-delivered phthalocyanines. This led to a greater efficiency and selectivity of tumour targeting. These effects were more pronounced for those GePcs having relatively long alkyl chains (hexyl to decyl) in the axial ligands. Maximal tumour accumulation (0.67 nmol per g of tissue) was found for Ge-Pc(hexyl)2 at 24 h after injection. Consistently, the Ge-Pc(hexyl)2, administered via Cremophor, showed the highest phototherapeutic activity towards MS-2 fibrosarcoma.
doi_str_mv 10.1038/bjc.1995.142
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2033732</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77211933</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3612-7f0e6f97924b06d6968f23f8743b39c2cbe2ee027d6689ddec82685ac118e7d33</originalsourceid><addsrcrecordid>eNptkc2KFDEUhYMoYzu6cyvUQkTBavNTnVQ2ggzjODDgRt2GVOqmO01VUiapYeoZfGnTdtMouAq558s54R6EXhK8Jpi1H7q9WRMpN2vS0EdoRTaM1qSl4jFaYYxFjSXFT9GzlPblKnErLtCFEARLxlfo17W1YHIVbKUfnB6qwW11dsFX2vdVD4O7h7hUaUkZxqqM8w6qPI9hjvUQjB5ccn77B66nXcghgU8uH6dTDBPE7CAd_G_g7e2Pd3UwWXdzDg9LeZB3urgs2jsP6Tl6YvWQ4MXpvETfP19_u_pS3329ub36dFcbxgmthcXArRSSNh3mPZe8tZTZVjSsY9JQ0wEFwFT0nLey78G0lLcbbQhpQfSMXaKPR99p7kboDfgc9aCm6EYdFxW0U_8q3u3UNtwrihkTjBaDNyeDGH7OkLIaXTIwDNpDmJMSghIi2SHp_RE0MaQUwZ5DCFaH8lQpTx3KU6W8gr_6-2Nn-NRW0V-fdJ3K6m3U3rh0xlgjRCNwweojloritxDVvtTly0r_H_sbeKi1Fw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77211933</pqid></control><display><type>article</type><title>Effect of axial ligation and delivery system on the tumour-localising and -photosensitising properties of Ge(IV)-octabutoxy-phthalocyanines</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Nature Journals Online</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Soncin, M ; Polo, L ; Reddi, E ; Jori, G ; Kenney, ME ; Cheng, G ; Rodgers, MAJ</creator><creatorcontrib>Soncin, M ; Polo, L ; Reddi, E ; Jori, G ; Kenney, ME ; Cheng, G ; Rodgers, MAJ</creatorcontrib><description>Four Ge(IV)-octabutoxy-phthalocyanines (GePcs) bearing two alkyl-type axial ligands were assayed for their pharmacokinetic properties and phototherapeutic efficiency in Balb/c mice bearing an intramuscularly transplanted MS-2 fibrosarcoma. The GePcs were i.v. injected at a dose of 0.35 mumol kg-1 body weight after incorporation into either Cremophor emulsions or small unilamellar liposomes of dipalmitoyl-phosphatidylcholine (DPPC). Both the nature of the delivery system and the chemical structure of the phthalocyanine were found to affect the behaviour of the GePcs in vivo. Thus, Cremophor-administered GePcs invariably yielded a more prolonged serum retention and a larger association with low-density lipoproteins (LDLs) as compared with the corresponding liposome-delivered phthalocyanines. This led to a greater efficiency and selectivity of tumour targeting. These effects were more pronounced for those GePcs having relatively long alkyl chains (hexyl to decyl) in the axial ligands. Maximal tumour accumulation (0.67 nmol per g of tissue) was found for Ge-Pc(hexyl)2 at 24 h after injection. Consistently, the Ge-Pc(hexyl)2, administered via Cremophor, showed the highest phototherapeutic activity towards MS-2 fibrosarcoma.</description><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/bjc.1995.142</identifier><identifier>PMID: 7710936</identifier><identifier>CODEN: BJCAAI</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>1,2-Dipalmitoylphosphatidylcholine ; Animals ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Drug Carriers ; Drug Resistance ; Emulsions ; Epidemiology ; experimental-oncology ; Female ; Fibrosarcoma - drug therapy ; Fibrosarcoma - metabolism ; Indoles - chemical synthesis ; Indoles - pharmacokinetics ; Indoles - therapeutic use ; Injections, Intravenous ; Lipoproteins, LDL - blood ; Liposomes ; Liver - metabolism ; Medical sciences ; Mice ; Mice, Inbred BALB C ; Molecular Medicine ; Muscles - metabolism ; Oncology ; Organometallic Compounds - chemical synthesis ; Organometallic Compounds - pharmacokinetics ; Organometallic Compounds - therapeutic use ; Photochemotherapy ; Photoradiation therapy and photosensitizing agent ; Polyethylene Glycols ; Radiation-Sensitizing Agents - pharmacokinetics ; Radiation-Sensitizing Agents - therapeutic use ; Skin - metabolism ; Spleen - metabolism ; Structure-Activity Relationship ; Treatment with physical agents ; Treatment. General aspects ; Tumors</subject><ispartof>British journal of cancer, 1995-04, Vol.71 (4), p.727-732</ispartof><rights>Cancer Research Campaign 1995</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3612-7f0e6f97924b06d6968f23f8743b39c2cbe2ee027d6689ddec82685ac118e7d33</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033732/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033732/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,41467,42536,51298,53770,53772</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3477470$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7710936$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Soncin, M</creatorcontrib><creatorcontrib>Polo, L</creatorcontrib><creatorcontrib>Reddi, E</creatorcontrib><creatorcontrib>Jori, G</creatorcontrib><creatorcontrib>Kenney, ME</creatorcontrib><creatorcontrib>Cheng, G</creatorcontrib><creatorcontrib>Rodgers, MAJ</creatorcontrib><title>Effect of axial ligation and delivery system on the tumour-localising and -photosensitising properties of Ge(IV)-octabutoxy-phthalocyanines</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><addtitle>Br J Cancer</addtitle><description>Four Ge(IV)-octabutoxy-phthalocyanines (GePcs) bearing two alkyl-type axial ligands were assayed for their pharmacokinetic properties and phototherapeutic efficiency in Balb/c mice bearing an intramuscularly transplanted MS-2 fibrosarcoma. The GePcs were i.v. injected at a dose of 0.35 mumol kg-1 body weight after incorporation into either Cremophor emulsions or small unilamellar liposomes of dipalmitoyl-phosphatidylcholine (DPPC). Both the nature of the delivery system and the chemical structure of the phthalocyanine were found to affect the behaviour of the GePcs in vivo. Thus, Cremophor-administered GePcs invariably yielded a more prolonged serum retention and a larger association with low-density lipoproteins (LDLs) as compared with the corresponding liposome-delivered phthalocyanines. This led to a greater efficiency and selectivity of tumour targeting. These effects were more pronounced for those GePcs having relatively long alkyl chains (hexyl to decyl) in the axial ligands. Maximal tumour accumulation (0.67 nmol per g of tissue) was found for Ge-Pc(hexyl)2 at 24 h after injection. Consistently, the Ge-Pc(hexyl)2, administered via Cremophor, showed the highest phototherapeutic activity towards MS-2 fibrosarcoma.</description><subject>1,2-Dipalmitoylphosphatidylcholine</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Drug Carriers</subject><subject>Drug Resistance</subject><subject>Emulsions</subject><subject>Epidemiology</subject><subject>experimental-oncology</subject><subject>Female</subject><subject>Fibrosarcoma - drug therapy</subject><subject>Fibrosarcoma - metabolism</subject><subject>Indoles - chemical synthesis</subject><subject>Indoles - pharmacokinetics</subject><subject>Indoles - therapeutic use</subject><subject>Injections, Intravenous</subject><subject>Lipoproteins, LDL - blood</subject><subject>Liposomes</subject><subject>Liver - metabolism</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Molecular Medicine</subject><subject>Muscles - metabolism</subject><subject>Oncology</subject><subject>Organometallic Compounds - chemical synthesis</subject><subject>Organometallic Compounds - pharmacokinetics</subject><subject>Organometallic Compounds - therapeutic use</subject><subject>Photochemotherapy</subject><subject>Photoradiation therapy and photosensitizing agent</subject><subject>Polyethylene Glycols</subject><subject>Radiation-Sensitizing Agents - pharmacokinetics</subject><subject>Radiation-Sensitizing Agents - therapeutic use</subject><subject>Skin - metabolism</subject><subject>Spleen - metabolism</subject><subject>Structure-Activity Relationship</subject><subject>Treatment with physical agents</subject><subject>Treatment. General aspects</subject><subject>Tumors</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkc2KFDEUhYMoYzu6cyvUQkTBavNTnVQ2ggzjODDgRt2GVOqmO01VUiapYeoZfGnTdtMouAq558s54R6EXhK8Jpi1H7q9WRMpN2vS0EdoRTaM1qSl4jFaYYxFjSXFT9GzlPblKnErLtCFEARLxlfo17W1YHIVbKUfnB6qwW11dsFX2vdVD4O7h7hUaUkZxqqM8w6qPI9hjvUQjB5ccn77B66nXcghgU8uH6dTDBPE7CAd_G_g7e2Pd3UwWXdzDg9LeZB3urgs2jsP6Tl6YvWQ4MXpvETfP19_u_pS3329ub36dFcbxgmthcXArRSSNh3mPZe8tZTZVjSsY9JQ0wEFwFT0nLey78G0lLcbbQhpQfSMXaKPR99p7kboDfgc9aCm6EYdFxW0U_8q3u3UNtwrihkTjBaDNyeDGH7OkLIaXTIwDNpDmJMSghIi2SHp_RE0MaQUwZ5DCFaH8lQpTx3KU6W8gr_6-2Nn-NRW0V-fdJ3K6m3U3rh0xlgjRCNwweojloritxDVvtTly0r_H_sbeKi1Fw</recordid><startdate>19950401</startdate><enddate>19950401</enddate><creator>Soncin, M</creator><creator>Polo, L</creator><creator>Reddi, E</creator><creator>Jori, G</creator><creator>Kenney, ME</creator><creator>Cheng, G</creator><creator>Rodgers, MAJ</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19950401</creationdate><title>Effect of axial ligation and delivery system on the tumour-localising and -photosensitising properties of Ge(IV)-octabutoxy-phthalocyanines</title><author>Soncin, M ; Polo, L ; Reddi, E ; Jori, G ; Kenney, ME ; Cheng, G ; Rodgers, MAJ</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3612-7f0e6f97924b06d6968f23f8743b39c2cbe2ee027d6689ddec82685ac118e7d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>1,2-Dipalmitoylphosphatidylcholine</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Drug Carriers</topic><topic>Drug Resistance</topic><topic>Emulsions</topic><topic>Epidemiology</topic><topic>experimental-oncology</topic><topic>Female</topic><topic>Fibrosarcoma - drug therapy</topic><topic>Fibrosarcoma - metabolism</topic><topic>Indoles - chemical synthesis</topic><topic>Indoles - pharmacokinetics</topic><topic>Indoles - therapeutic use</topic><topic>Injections, Intravenous</topic><topic>Lipoproteins, LDL - blood</topic><topic>Liposomes</topic><topic>Liver - metabolism</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Molecular Medicine</topic><topic>Muscles - metabolism</topic><topic>Oncology</topic><topic>Organometallic Compounds - chemical synthesis</topic><topic>Organometallic Compounds - pharmacokinetics</topic><topic>Organometallic Compounds - therapeutic use</topic><topic>Photochemotherapy</topic><topic>Photoradiation therapy and photosensitizing agent</topic><topic>Polyethylene Glycols</topic><topic>Radiation-Sensitizing Agents - pharmacokinetics</topic><topic>Radiation-Sensitizing Agents - therapeutic use</topic><topic>Skin - metabolism</topic><topic>Spleen - metabolism</topic><topic>Structure-Activity Relationship</topic><topic>Treatment with physical agents</topic><topic>Treatment. General aspects</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Soncin, M</creatorcontrib><creatorcontrib>Polo, L</creatorcontrib><creatorcontrib>Reddi, E</creatorcontrib><creatorcontrib>Jori, G</creatorcontrib><creatorcontrib>Kenney, ME</creatorcontrib><creatorcontrib>Cheng, G</creatorcontrib><creatorcontrib>Rodgers, MAJ</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Soncin, M</au><au>Polo, L</au><au>Reddi, E</au><au>Jori, G</au><au>Kenney, ME</au><au>Cheng, G</au><au>Rodgers, MAJ</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of axial ligation and delivery system on the tumour-localising and -photosensitising properties of Ge(IV)-octabutoxy-phthalocyanines</atitle><jtitle>British journal of cancer</jtitle><stitle>Br J Cancer</stitle><addtitle>Br J Cancer</addtitle><date>1995-04-01</date><risdate>1995</risdate><volume>71</volume><issue>4</issue><spage>727</spage><epage>732</epage><pages>727-732</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><coden>BJCAAI</coden><abstract>Four Ge(IV)-octabutoxy-phthalocyanines (GePcs) bearing two alkyl-type axial ligands were assayed for their pharmacokinetic properties and phototherapeutic efficiency in Balb/c mice bearing an intramuscularly transplanted MS-2 fibrosarcoma. The GePcs were i.v. injected at a dose of 0.35 mumol kg-1 body weight after incorporation into either Cremophor emulsions or small unilamellar liposomes of dipalmitoyl-phosphatidylcholine (DPPC). Both the nature of the delivery system and the chemical structure of the phthalocyanine were found to affect the behaviour of the GePcs in vivo. Thus, Cremophor-administered GePcs invariably yielded a more prolonged serum retention and a larger association with low-density lipoproteins (LDLs) as compared with the corresponding liposome-delivered phthalocyanines. This led to a greater efficiency and selectivity of tumour targeting. These effects were more pronounced for those GePcs having relatively long alkyl chains (hexyl to decyl) in the axial ligands. Maximal tumour accumulation (0.67 nmol per g of tissue) was found for Ge-Pc(hexyl)2 at 24 h after injection. Consistently, the Ge-Pc(hexyl)2, administered via Cremophor, showed the highest phototherapeutic activity towards MS-2 fibrosarcoma.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>7710936</pmid><doi>10.1038/bjc.1995.142</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-0920
ispartof British journal of cancer, 1995-04, Vol.71 (4), p.727-732
issn 0007-0920
1532-1827
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2033732
source MEDLINE; Springer Nature - Complete Springer Journals; Nature Journals Online; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects 1,2-Dipalmitoylphosphatidylcholine
Animals
Biological and medical sciences
Biomedical and Life Sciences
Biomedicine
Cancer Research
Drug Carriers
Drug Resistance
Emulsions
Epidemiology
experimental-oncology
Female
Fibrosarcoma - drug therapy
Fibrosarcoma - metabolism
Indoles - chemical synthesis
Indoles - pharmacokinetics
Indoles - therapeutic use
Injections, Intravenous
Lipoproteins, LDL - blood
Liposomes
Liver - metabolism
Medical sciences
Mice
Mice, Inbred BALB C
Molecular Medicine
Muscles - metabolism
Oncology
Organometallic Compounds - chemical synthesis
Organometallic Compounds - pharmacokinetics
Organometallic Compounds - therapeutic use
Photochemotherapy
Photoradiation therapy and photosensitizing agent
Polyethylene Glycols
Radiation-Sensitizing Agents - pharmacokinetics
Radiation-Sensitizing Agents - therapeutic use
Skin - metabolism
Spleen - metabolism
Structure-Activity Relationship
Treatment with physical agents
Treatment. General aspects
Tumors
title Effect of axial ligation and delivery system on the tumour-localising and -photosensitising properties of Ge(IV)-octabutoxy-phthalocyanines
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T11%3A41%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20axial%20ligation%20and%20delivery%20system%20on%20the%20tumour-localising%20and%20-photosensitising%20properties%20of%20Ge(IV)-octabutoxy-phthalocyanines&rft.jtitle=British%20journal%20of%20cancer&rft.au=Soncin,%20M&rft.date=1995-04-01&rft.volume=71&rft.issue=4&rft.spage=727&rft.epage=732&rft.pages=727-732&rft.issn=0007-0920&rft.eissn=1532-1827&rft.coden=BJCAAI&rft_id=info:doi/10.1038/bjc.1995.142&rft_dat=%3Cproquest_pubme%3E77211933%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77211933&rft_id=info:pmid/7710936&rfr_iscdi=true